Latest Protein kinase inhibitor Stories
Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene.
LUXEMBOURG, August 18, 2011 /PRNewswire/ -- Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, inflammation and pain, announced today the expansion of its senior management team with the appointment of three experienced international pharma executives.
SUNNYVALE, Calif., Aug. 9, 2011 /PRNewswire/ -- Pharmacyclics, Inc.
SAN DIEGO, Aug. 3, 2011 /PRNewswire/ -- Proacta Incorporated and Yakult Honsha Co., Ltd.
(Ivanhoe Newswire) "“ A new study reveals that cancer patients treated with the drugs sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared. "The damage that chemotherapy does to normal, healthy cells as it treats cancer has been well documented, but the precise effect that the new class of targeted agents has on the immune system is less well known. This study helps us answer that question," Keith...
Patients treated with sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared.
DALLAS, June 23, 2011 /PRNewswire/ -- - ReportsnReports announces it will carry 'Multitargeted Therapies: Promiscuous Drugs and Combination Therapies'Report in its store Browse the complete 'Multitargeted Therapies: Promiscuous Drugs and Combination Therapies [http://www.reportsnreports.com/reports/89350-multitargeted-therapies-promiscuous-drugs-and-combination-therap.html ] 'Report now! Search 75000+ Market Research Reports [http://www.reportsnreports.com ]...
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.